Clinical Trial Update: Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating Epstein-Barr virus-targeted CAR-T/TCR-T cell therapy for nasopharyngeal carcinoma, currently recruiting at Fudan Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• EBV CAR-T / TCR-T Cells

Snippet

Sponsor: Fudan University | Conditions: Nasopharyngeal Carcinoma | EARLY_Phase 1 | Status: RECRUITING